DuoGenic StemCells (ROCO:7607) COGS-to-Revenue : 0.55 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells COGS-to-Revenue?

DuoGenic StemCells's Cost of Goods Sold for the six months ended in Dec. 2024 was NT$3.80 Mil. Its Revenue for the six months ended in Dec. 2024 was NT$6.96 Mil.

DuoGenic StemCells's COGS to Revenue for the six months ended in Dec. 2024 was 0.55.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DuoGenic StemCells's Gross Margin % for the six months ended in Dec. 2024 was 45.39%.

DuoGenic StemCells COGS-to-Revenue Historical Data

The historical data trend for DuoGenic StemCells's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells COGS-to-Revenue Chart

DuoGenic StemCells Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

2.39

0.66

0.64

0.66

DuoGenic StemCells Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial			0.54	0.62	0.67	0.81	0.55

DuoGenic StemCells COGS-to-Revenue Calculation

DuoGenic StemCells's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.949	/	12.052
	=	0.66

DuoGenic StemCells's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.801	/	6.96
	=	0.55

DuoGenic StemCells (ROCO:7607) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DuoGenic StemCells's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3.801 / 6.96
	=	45.39 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

DuoGenic StemCells COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DuoGenic StemCells Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN

Website

https://www.dgsc.com.tw

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines